BK

Bobby Kurian

Active Director Director DIN 07865524
DIN 07865524 First appointment Feb 2018 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Feb 2018
Shareholding value Locked Premium profile

About Bobby Kurian

Data last updated:

Bobby Kurian has 8 years in corporate governance. Holds Director role. Currently with 1 company, including Sanfegan Biotech Private Limited. Engaged in Technology. Contributes to corporate operations.

DIN 07865524
Primary Designation Director
First Appointment 22 Feb 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedStatus
Sanfegan Biotech Private Limited U74999KL2018PTC052096
Director22 Feb 20182018Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sanfegan Biotech Private Limited
Premium access

Shareholding and investment profile for Bobby Kurian

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bobby Kurian

Bobby Kurian has 8 years in corporate governance. Holds Director role. Currently with 1 company, including Sanfegan Biotech Private Limited. Engaged in Technology. Contributes to corporate operations.

Bobby Kurian is associated with 1 company as Director.

Bobby Kurian has expertise in Technology.

Bobby Kurian has 8 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available